Latest Regulatory Milestones News

Theta Gold Mines reports significant progress in funding discussions, plant construction, and resource integration for its TGME gold project in South Africa during Q1 2025.

HALO Technologies reports solid quarterly revenue growth and nears completion of a $6.75 million capital raise, while progressing its UK wealth management platform launch and preparing to introduce Managed Funds in Australia.

Admiralty Resources NL has made significant strides in ramping up production at its Mariposa Iron Ore Project in Chile, delivering 100,000 tonnes of high-grade concentrate and progressing key infrastructure and regulatory approvals during the March 2025 quarter.

Talga Group advances its European battery materials ambitions with EU Strategic Project recognitions for its graphite mine and anode refinery, alongside a €70 million Innovation Fund grant.

Black Rock Mining advances its Mahenge Graphite Project with a A$5 million placement and POSCO’s strategic US$277 million investment in a Korean spherical graphite plant, signaling strengthened downstream integration and project momentum.

Clarity Pharmaceuticals reports a robust cash position and strategic refocus on its lead prostate cancer asset, Cu-SAR-bisPSMA, supported by multiple FDA Fast Track designations and advancing clinical trials.

Bindi Metals progresses its Lisa Project application with Serbia’s Ministry while identifying promising gold and antimony drill targets, maintaining a solid cash position of $1.734 million.

Enova Mining reports significant high-grade titanium discoveries at its CODA North and Central projects in Brazil, supported by a $1.5 million placement to accelerate exploration and development.

Dimerix Limited advances its Phase 3 kidney disease trial with FDA acceptance of proteinuria as a primary endpoint and clinches a lucrative licensing agreement in Japan worth up to AU$107 million plus royalties.

TrivarX has launched a pivotal mental health clinical trial in partnership with the US Department of Veterans Affairs, leveraging its innovative ECG-based technology to screen for major depressive episodes. The company also secured $2.25 million in funding, positioning it for regulatory milestones ahead.

Hydrix Limited reports improved operating performance in Q3 FY25, buoyed by FDA clearance of its Gyder Surgical Hip Navigation system and a reduced cash operating loss, while managing tight liquidity with shareholder support.

Blue Energy has resolved a significant legal hurdle by securing an amended Environmental Authority for its Sapphire asset, enabling progression of the Petroleum Lease 1034 and continued pilot production testing despite operational interruptions.